Detection of neoantigen-specific CD8+ and CD4+ lymphocytes from peripheral blood has been subsequently described in patients with relatively low tumor mutation burden, such as ovarian and gastrointesinal cancers (20, 38–40). Here, CD4 is linked to neoplasm.